Nail Changes: Labs, Diagnosis, and Next Steps

Why Nails Change and What They Reveal

Nails grow from the matrix at the proximal nail fold, and disruptions anywhere along the matrix, nail bed, or surrounding tissue produce visible abnormalities. A 2019 review in the Indian Dermatology Online Journal found that nail disorders accounted for approximately 10% of all dermatologic conditions seen in outpatient settings [1]. That percentage climbs in older adults. Onychomycosis alone affects an estimated 10% of the general population, rising to 20% in people over age 60 and nearly 50% in those over 70, according to data published in the Journal of Clinical and Aesthetic Dermatology [2].

The nail unit responds to systemic illness in predictable ways. Horizontal depressions (Beau's lines) reflect a temporary arrest of matrix activity during acute illness or metabolic stress. Pitting suggests psoriasis or alopecia areata. Koilonychia points to iron deficiency. Clubbing raises concern for cardiopulmonary disease. These patterns are diagnostically useful only when matched with the right laboratory and clinical data, which is why a structured workup matters more than visual pattern recognition alone [3].

Not every nail change requires urgent evaluation. But any change that is isolated to a single digit, progressing over weeks, or accompanied by pain or periungual tissue changes warrants prompt assessment.

The First-Line Laboratory Panel

Order a targeted blood panel before assuming a nail change is cosmetic or age-related. The American Academy of Dermatology recommends a baseline evaluation that includes CBC with differential, serum ferritin, TSH, free T4, 25-hydroxyvitamin D, and zinc when evaluating unexplained nail dystrophy [4]. Ferritin is the most sensitive early marker for iron depletion. A 2020 study in Clinical and Experimental Dermatology found that 42% of patients with diffuse nail brittleness had ferritin levels below 30 ng/mL, even when hemoglobin remained normal [5].

TSH and free T4 are non-negotiable. A retrospective chart review published in Thyroid reported that 93% of patients with overt hypothyroidism had at least one nail finding, most commonly brittleness and slow growth [6]. Hyperthyroidism produces a different pattern: Plummer's nails (onycholysis of the distal plate) appeared in 33% of Graves' disease patients in one series.

Add serum albumin, prealbumin, and a comprehensive metabolic panel if malnutrition or chronic disease is suspected. For patients on antiretroviral therapy or chemotherapy, drug-induced nail changes are common, and the temporal relationship between medication initiation and symptom onset usually clinches the diagnosis.

Fungal Testing: KOH, Culture, and PCR

Onychomycosis is overdiagnosed clinically and undertreated when confirmed. A landmark analysis in the British Journal of Dermatology showed that clinical diagnosis alone had a sensitivity of only 50 to 60%, meaning nearly half of clinically suspected fungal nails were something else entirely [7]. This is why laboratory confirmation is mandatory before prescribing systemic antifungals, which carry hepatotoxic risk.

Three testing methods are standard. KOH preparation gives results in minutes but has a sensitivity of about 73% in experienced hands [7]. Fungal culture on Sabouraud's agar remains the diagnostic gold standard, identifying the species (most commonly Trichophyton rubrum) in 3 to 4 weeks. PAS staining of nail clippings, sometimes called the histopathologic approach, offers sensitivity exceeding 90% according to a 2007 study in the Journal of the American Academy of Dermatology and is increasingly used as a first-line confirmatory test [8]. PCR-based assays are faster but not universally available.

Dr. Boni Elewski, a dermatologist at the University of Alabama at Birmingham, has stated: "Treating onychomycosis without confirming the fungus is like prescribing antibiotics without a culture. You may be treating the wrong pathogen, or no pathogen at all" [7].

Proper specimen collection matters as much as the test chosen. Clip the dystrophic nail plate, then scrape subungual debris from the most proximal affected area, where viable organisms concentrate. Distal clippings alone yield high false-negative rates.

When to Biopsy: Clinical Decision Rules

Nail biopsy is underused. A punch or excisional biopsy of the nail matrix or bed is indicated in three scenarios: longitudinal melanonychia in adults (especially those over 50 or with a single affected digit), nail dystrophy persisting beyond six months without a clear diagnosis, and any suspicion of squamous cell carcinoma or melanoma [9].

Subungual melanoma accounts for 0.7 to 3.5% of all melanoma cases in fair-skinned populations but up to 20% in Black, Hispanic, and Asian patients, according to a 2009 review in the Journal of the American Academy of Dermatology [10]. The ABCDEF mnemonic (Age/race, Band, Change, Digit most commonly affected, Extension of pigment to the proximal nail fold [Hutchinson's sign], Family history) guides biopsy decisions. A single dark longitudinal band that is widening, irregular in color, or broader than 3 mm on the thumb, index finger, or great toe demands biopsy without delay.

Dr. Richard Scher, a nail specialist formerly at Weill Cornell Medicine, has emphasized: "Any melanonychia that is new, changing, or solitary in a patient over 50 should be biopsied. Watching and waiting costs lives when subungual melanoma is in the differential" [10].

The biopsy technique depends on the target. A 3-mm punch through the nail plate into the matrix is standard for pigmented bands. Nail bed biopsies for inflammatory or tumorous conditions may require partial or full nail avulsion under digital block.

Nail Changes Linked to Systemic Disease

Specific nail findings map to systemic diagnoses with varying reliability. Clubbing (an increase in the Lovibond angle beyond 180 degrees) has been associated with pulmonary malignancy, interstitial lung disease, cyanotic heart disease, inflammatory bowel disease, and hepatic cirrhosis. A prospective study in CHEST found that new-onset clubbing had a positive predictive value of 40% for underlying malignancy, primarily lung cancer, when no other cause was identified [11].

Terry's nails (white nail beds with a narrow distal pink band) occur in up to 80% of patients with hepatic cirrhosis [12]. Half-and-half nails (Lindsay's nails), where the proximal half is white and the distal half is brown, appear in 20 to 40% of patients with chronic kidney disease [12]. Muehrcke's lines (paired transverse white bands that disappear with pressure) signal hypoalbuminemia below 2.2 g/dL and resolve when albumin normalizes [12].

Splinter hemorrhages in the nail bed are commonly traumatic, but when multiple digits are involved and the patient is febrile, infective endocarditis enters the differential. The 2023 Duke criteria still include splinter hemorrhages among minor criteria for endocarditis diagnosis [13].

Yellow nail syndrome, characterized by thickened, slow-growing, yellow-green nails with loss of cuticle, is associated with lymphedema and pleural effusions. It is rare (estimated prevalence below 1 per 1,000,000) but clinically distinct enough that the triad itself is often diagnostic without biopsy [3].

Nutritional and Hormonal Drivers

Iron deficiency produces koilonychia. This finding is most specific when ferritin drops below 20 ng/mL, though it can appear at levels up to 30 ng/mL in patients with concurrent inflammation. Oral iron replacement (ferrous sulfate 325 mg daily, taken with vitamin C to improve absorption) typically corrects koilonychia over 3 to 6 months as the new nail plate grows out [5].

Biotin deficiency causes brittle nails, but supplementation data is limited. A 2017 systematic review in the Journal of Dermatological Treatment found only three small trials (total N = 131) assessing biotin for nail brittleness, with improvement reported in open-label designs but no placebo-controlled confirmation [14]. The effective dose in these studies was 2.5 mg daily for at least 6 months.

Zinc deficiency, confirmed by serum zinc below 60 mcg/dL, causes nail dystrophy including Beau's lines and leukonychia. Replacement with zinc gluconate 50 mg daily (containing about 7 mg elemental zinc) for 8 to 12 weeks is standard.

Thyroid-driven nail changes respond to hormone normalization. Patients with hypothyroidism placed on levothyroxine (typical starting dose 1.6 mcg/kg/day) who reach a TSH between 0.5 and 2.5 mIU/L generally see nail texture and growth rate improve within 4 to 6 months [6]. For women on hormone replacement therapy, estrogen's effect on nail quality is modest but measurable: a small trial in Maturitas found a 15% improvement in nail hardness after 6 months of transdermal estradiol [15].

Treatment Pathways by Diagnosis

Treatment depends entirely on the confirmed diagnosis. For onychomycosis, terbinafine 250 mg daily for 12 weeks (toenails) or 6 weeks (fingernails) remains first-line, with mycologic cure rates of 70 to 76% in the LION study [16]. Itraconazole pulse therapy (200 mg twice daily for one week per month, repeated for 3 to 4 months) is an alternative for patients who cannot tolerate terbinafine or who take medications with CYP3A4 interactions. Topical efinaconazole 10% solution, applied daily for 48 weeks, achieved complete cure in 15 to 18% of patients in two phase III trials, making it a reasonable option only for mild, distal disease [17].

Psoriatic nail disease responds to systemic psoriasis therapies. Biologics targeting IL-17 or IL-23 show the strongest nail-specific data. In the TRANSFIGURE trial, secukinumab 300 mg produced a 63.6% improvement in NAPSI (Nail Psoriasis Severity Index) scores at week 32 versus 10.8% for placebo [18]. Intralesional triamcinolone (2.5 to 5 mg/mL injected into the proximal nail fold monthly for 3 to 6 months) is effective for isolated nail psoriasis but painful, and patient adherence is often limited.

For melanonychia confirmed as benign by biopsy, serial clinical photography every 6 months with dermoscopic evaluation is the standard surveillance protocol. Subungual melanoma requires wide excision, typically amputation of the distal phalanx, with sentinel lymph node biopsy for lesions thicker than 0.8 mm [10].

Building a Stepwise Evaluation Plan

Start with history. Ask about duration, number of nails affected, associated skin changes, medications, occupational exposures, and family history of psoriasis or melanoma. A single affected nail points toward trauma, tumor, or focal infection. Multiple nails suggest systemic disease or a dermatologic condition.

Step two is the targeted lab panel: CBC, ferritin, TSH, free T4, vitamin D, zinc. Add CMP, ESR, and CRP if an inflammatory or systemic process is suspected.

Step three is microbiologic confirmation for any suspected fungal nail. Never treat empirically.

Step four is referral. Dermatology referral is appropriate for melanonychia, any nail change requiring biopsy, psoriatic nail disease unresponsive to topical therapy, and nail dystrophy persisting beyond 6 months without a diagnosis. If clubbing is new, order a chest X-ray and consider pulmonary or cardiology referral based on findings.

Patients with confirmed nutritional deficiencies should have labs rechecked at 3 months post-supplementation and nail reassessment at 6 months, since fingernails take roughly 6 months and toenails 12 to 18 months to grow out completely [3].